Tick-Borne Disease Research Aims to Develop New Vaccines

A Kansas State University professor is researching ways to keep animals and humans safe from tick-borne diseases.

Written byKansas State University
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00

Roman Ganta, professor of diagnostic medicine and pathobiology, has received a four-year $1.8 million National Institutes of Health grant to continue studying the tick-borne bacterium Ehrlichia chaffeensis. With the latest grant, Ganta now has 16 years of continuous NIH funding for his research related to tick-borne pathogens.

By studying the genetic makeup of E. chaffeensis, Ganta and his research team plan to develop vaccines to protect against infections from E. chaffeensis and other similar tick-borne pathogens.

To continue reading this article, sign up for FREE to
Lab Manager Logo
Membership is FREE and provides you with instant access to eNewsletters, digital publications, article archives, and more.

CURRENT ISSUE - October 2025

Turning Safety Principles Into Daily Practice

Move Beyond Policies to Build a Lab Culture Where Safety is Second Nature

Lab Manager October 2025 Cover Image